Submitted by Anonymous (not verified) on 13 November 2024 - 9:00
ETF statement on the use of Imvanex for the prevention of mpox in children below 12 years of age
Source:
ETF statement on the use of Imvanex for the prevention of mpox in children below 12 years of age